Kevin J. Tracey, MD, the president and CEO of Northwell Health's Feinstein Institutes for Medical Research in Manhasset, received the Double Helix Medal from Cold Spring Harbor Laboratory on November 10. The medal recognized his work founding bioelectronic medicine, a field built on his discovery that a single nerve helps the body switch inflammation off, and that a small implanted device can do that job in place of a drug.
Tracey shared the evening with philanthropist Michael Milken, the night's other honoree, at the laboratory's annual Double Helix Medals Dinner in New York City, which drew more than 450 people from science, medicine and philanthropy.
Two Long Island research institutions, one honor
The award connects two Long Island research institutions. Cold Spring Harbor Laboratory, founded in 1890 on the harbor of the same name, is often called the birthplace of molecular biology and counts eight Nobel Prize winners among its scientists. The Feinstein Institutes are Northwell's research arm, headquartered in Manhasset, and now span six institutes with more than 50 labs and 5,000 researchers and staff.
The Double Helix Medal goes to people who have made major breakthroughs in biomedical research and to those who have raised support or awareness for science and medicine. Past recipients include Nobel laureates Jennifer Doudna, Katalin Karikó and Jim Allison, along with Muhammad Ali, Michael J. Fox, Kareem Abdul-Jabbar, Katie Couric and Marlo Thomas.
The discovery behind it
In 2002, Tracey published a paper in the journal Nature describing what he called the inflammatory reflex: the way the vagus nerve, which runs from the brain stem down through the chest and abdomen, signals the immune system and keeps inflammation in check. The finding meant that a nerve, and not only a medication, could be used to calm the immune overreaction behind chronic inflammatory disease.
That idea has since moved from the lab into patients. Tracey's research directly informed the SetPoint System, an implanted device that stimulates the vagus nerve and was approved by the U.S. Food and Drug Administration in 2025 for rheumatoid arthritis. It is the first therapy for the condition that works without a drug, and Northwell was the first health system in the country to implant it. The same discovery laid the groundwork for implanted devices aimed at other chronic inflammatory conditions, including Crohn's disease and sepsis.
A run of recognition
The medal follows other honors for Tracey this year and last. He was named an Innovator on TIME's 2026 TIME100 Health list, was elected a Fellow of the Royal Swedish Academy of Engineering Sciences, and was inducted into the National Academy of Inventors as part of its Class of 2025, specifically for the inflammatory reflex and the field it started. He is also the author of The Great Nerve, a book for general readers about the vagus nerve and how its reflexes might be put to medical use.
In Northwell's announcement, Tracey credited his lab colleagues, industry partners, and the physicians and patients who were willing to try a new approach.
For Long Island patients
Northwell's Center for Bioelectronic Medicine at the Feinstein Institutes runs research and clinical programs in the field, and the health system offers a patient navigator for people who want to learn whether a bioelectronic treatment or clinical trial might apply to them. Information is on the Feinstein Institutes website.

Loading comments…